Alliance A221602

Olanzapine With Or Without Fosaprepitant For The Prevention Of Chemotherapy Induced Nausea And Vomiting (CINV) In Patients Receiving Highly Emetogenic Chemotherapy (HEC): A Phase III Randomized, Double-Blind, Placebo-Controlled Trial

For more information about this clinical trial, click here

Schema & Eligibility Alliance A221602

Available at:

CoxHealth Medical Center, Springfield, MO
Good Samaritan Regional Health Center, Mt. Vernon, IL
Mercy Hospital, Springfield, MO
Mercy Hospital, Joplin, MO
Mercy Clinic, Rolla, MO
Mercy Hospital, St. Louis, MO

Ask your physician about participating in this clinical trial or call us.